STOCK TITAN

Dan Puckett joins PROCEPT BioRobotics (PRCT) board in Form 3 filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

PROCEPT BioRobotics Corp director Dan Puckett filed an initial ownership report on Form 3. The filing lists him as a director of the company and does not report any share purchases, sales, acquisitions, or dispositions at this time.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
PUCKETT DAN

(Last) (First) (Middle)
150 BAYTECH DR.

(Street)
SAN JOSE CA 95134

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/05/2026
3. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
No securities are beneficially owned.
/s/ Jonathan Stone, Attorney-in-Fact for Dan Puckett 03/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the PROCEPT BioRobotics (PRCT) Form 3 for Dan Puckett show?

The Form 3 filing shows that Dan Puckett is a director of PROCEPT BioRobotics Corp. It is an initial ownership report and does not list any stock purchases, sales, acquisitions, or dispositions.

Did Dan Puckett buy or sell PRCT shares in this Form 3 filing?

No, this Form 3 does not report any buy or sell transactions. The transaction summary shows zero purchases, zero sales, and no net change in reported share ownership activity.

What insider role is disclosed for Dan Puckett at PROCEPT BioRobotics?

The filing identifies Dan Puckett as a director of PROCEPT BioRobotics Corp. He is not listed as an officer or ten-percent owner in this Form 3 submission.

Does the PRCT Form 3 for Dan Puckett include any footnote disclosures?

Yes, the Form 3 includes a footnote section, but the provided content shows it as empty. No additional explanatory ownership details or disclaimers are disclosed in the available excerpt.

What is the net buy or sell direction in Dan Puckett’s PRCT Form 3?

The transaction summary shows a neutral net buy/sell direction. Buy, sell, acquire, dispose, and other transaction counts are all zero, indicating no reported trading activity in this filing.
Procept Biorobotics Corp

NASDAQ:PRCT

View PRCT Stock Overview

PRCT Rankings

PRCT Latest News

PRCT Latest SEC Filings

PRCT Stock Data

1.47B
53.88M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SAN JOSE